CD1-MR1 2025
Chair: Hui-Fern Koay
Patient-derived pancreatic tumor bacteria exhibit oncogenic properties and are recognized by MAIT cells in tumor spheroids (#14)
4:35 PM
Advances in the characterisation of antigen presentation by group 1 CD1 antigen-presenting molecules (#15)
4:37 PM
Understanding the molecular basis of autoreactive T cell recognition of CD1a presenting self-lipid antigen (#16)
4:39 PM
Investigating the role of CD1a and CD1d in Nickel Allergic Contact Dermatitis (#17)
4:41 PM
Generative Diffusion-Based De Novo Protein Design of Lipid/CD1-Restricted TCR Mimics (#18)
4:43 PM
Small molecules from conserved metabolic pathways form alternate 5-A-RU-based MR1 ligands that are recognised by MAIT cells (#19)
4:45 PM
Antibody-dependent cellular cytotoxicity of iPS cell-derived natural killer T cells by anti-GD2 mAb for neuroblastoma (#20)
4:47 PM
Characterization of bile acids as novel MR1 ligands (#21)
4:49 PM